Pulvermüller A, Maretzki D, Rudnicka-Nawrot M, Smith W C, Palczewski K, Hofmann K P
Institut für Medizinische Physik und Biophysik, Charité, Medizinische Fakultät der Humboldt-Universität zu Berlin, Ziegelstrasse 5-9, 10098 Berlin, Germany.
Biochemistry. 1997 Jul 29;36(30):9253-60. doi: 10.1021/bi970772g.
Arrestin quenches signal transduction in rod photoreceptors by blocking the catalytic activity of photoactivated phosphorylated rhodopsin toward the G protein, transducin (Gt). Rod cells also express a splice variant of arrestin, termed p44, in which the last 35 amino acids are replaced by a single Ala. In contrast to arrestin, this protein has been reported to bind to both the phosphorylated and nonphosphorylated forms of the activated receptor. In this study, we analyzed formation of the rhodopsin-p44 complex in vitro. Like arrestin, p44 stabilized the meta II (MII) photoproduct relative to forms MI and MIII and did not interact measurably with the apoprotein opsin. However, several differences between p44 and its parent protein were found: (i) p44 binds to nonphosphorylated MII with a much lower affinity (KD = 0.24 microM) than to phosphorylated MII (P-MII) (KD = 12 nM); arrestin binds only to P-MII (KD = 20 nM); (ii) p44 interacted also with truncated MII (329G-Rho MII), which lacked the sites of phosphorylation; (iii) with both MII and P-MII, the activation energy of complex formation with p44 was lower than that found for arrestin (70 kJ/mol instead of 140 kJ/mol); and (iv) InsP6 inhibited poorly the interaction between p44 and P-MII, but it strongly inhibited the interaction between arrestin and P-MII. Extrapolation of the measured on-rates to physiological conditions yielded reaction times for the binding of p44 to activated rhodopsin. The data suggest that the splice variant, p44, and its parent protein, arrestin, play different roles in phototransduction. The physiological significance of these differences remains to be determined.
抑制蛋白通过阻断光激活的磷酸化视紫红质对G蛋白转导素(Gt)的催化活性来终止视杆光感受器中的信号转导。视杆细胞还表达一种抑制蛋白的剪接变体,称为p44,其最后35个氨基酸被单个丙氨酸取代。与抑制蛋白不同,据报道这种蛋白能与活化受体的磷酸化和非磷酸化形式结合。在本研究中,我们在体外分析了视紫红质-p44复合物的形成。与抑制蛋白一样,p44相对于MI和MIII形式稳定了间态II(MII)光产物,并且与脱辅基蛋白视蛋白没有可测量的相互作用。然而,发现p44与其亲本蛋白之间存在几个差异:(i)p44与非磷酸化MII的结合亲和力(KD = 0.24 microM)远低于与磷酸化MII(P-MII)的结合亲和力(KD = 12 nM);抑制蛋白仅与P-MII结合(KD = 20 nM);(ii)p44还与缺少磷酸化位点的截短MII(329G-Rho MII)相互作用;(iii)对于MII和P-MII,与p44形成复合物的活化能低于抑制蛋白(70 kJ/mol而不是140 kJ/mol);(iv)肌醇六磷酸(InsP6)对p44与P-MII之间相互作用的抑制作用较弱,但它强烈抑制抑制蛋白与P-MII之间的相互作用。将测得的结合速率外推到生理条件下,得出p44与活化视紫红质结合的反应时间。数据表明,剪接变体p44及其亲本蛋白抑制蛋白在光转导中发挥不同作用。这些差异的生理意义尚待确定。